VRE acquisition in hospital and its association with hospital antimicrobial usage -a non-linear analysis of an extended time series.

Ferguson, J K; Chiu, S; Oldmeadow, C; Deane, J; Munnoch, S; Fraser, N

Ferguson, J K; Chiu, S; Oldmeadow, C; Deane, J; Munnoch, S; Fraser, N.

Afiliação

Ferguson JK; John Hunter Hospital, Newcastle, NSW, Australia; University of Newcastle, NSW, Australia. Electronic address: john.ferguson@health.nsw.gov.au.
Chiu S; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Deane J; Infection Prevention Service, Hunter New England Health Service, NSW, Australia.
Munnoch S; Infection Prevention Service, Hunter New England Health Service, NSW, Australia.
Fraser N; Hunter New England Population Health Unit, NSW, Australia.

Infect Dis Health ; 28(3): 151-158, 2023 08.

Article em En | MEDLINE | ID: mdl-36803829

Assuntos

Anti-Infecciosos; Enterococos Resistentes à Vancomicina; Humanos; Fatores de Tempo; Austrália; Antibacterianos/uso terapêutico; Centros de Atenção Terciária; Combinação Piperacilina e Tazobactam

Palavras-chave

Amoxicillin/clavulanate; Antimicrobial stewardship; Healthcare-associated infection; Piperacillin/tazobactam; VRE; Vancomycin-resistant enterococcus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enterococos Resistentes à Vancomicina / Anti-Infecciosos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Infect Dis Health Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google